These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 124227

  • 1. [Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].
    Hausnerová S, Tesarová Z, Uhlír O.
    Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):97-101. PubMed ID: 124227
    [No Abstract] [Full Text] [Related]

  • 2. [5-Nok in the treatment of candidiasis].
    Ljubojević S, Perinović M, Kesić V.
    Med Arh; 1975 Mar; 29(6):643-4. PubMed ID: 814373
    [No Abstract] [Full Text] [Related]

  • 3. [1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].
    Schlesinger E, Patsch R, Kraft M.
    Z Urol Nephrol; 1975 Jun; 70(6):429-34. PubMed ID: 810992
    [No Abstract] [Full Text] [Related]

  • 4. Oxolinic acid, nalidixic acid and 5Nok in the treatment of urinary tract infections.
    Balogh F, Köves S, Kocsis B.
    Ther Hung; 1978 Jun; 26(1):20-3. PubMed ID: 96544
    [No Abstract] [Full Text] [Related]

  • 5. [Bacteriological and clinical evaluation of a dicloxacillin-ampicillin combination (author's transl)].
    Abbate GF, Leonessa V, Altucci P.
    Arzneimittelforschung; 1978 Jun; 28(6):1008-13. PubMed ID: 581996
    [Abstract] [Full Text] [Related]

  • 6. [Sensitivity of E. coli to intestopan].
    Sedova NN.
    Lab Delo; 1980 Jun; (8):493-4. PubMed ID: 6157907
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical--bacteriological study of dibekacine in urinary infections].
    Mallo N, Dalet F.
    Rev Clin Esp; 1979 Dec 31; 155(6):417-21. PubMed ID: 397556
    [No Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of urinary infections].
    Dureux JB, Canton P, Léger C.
    Rev Prat; 1979 Aug 31; 29(37):2903-9. PubMed ID: 118507
    [No Abstract] [Full Text] [Related]

  • 9. [Use of isoniazid with nitrofuran and 5-NHQ derivatives in experimental tuberculosis].
    Il'ina TB, Vishnevskiĭ BI, Efremova IIa, Vavilin GI.
    Probl Tuberk; 1976 Aug 31; (8):51-5. PubMed ID: 826902
    [No Abstract] [Full Text] [Related]

  • 10. [Recent research on derivatives of 8-oxyquinoline. New 7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines and 5-chloro-7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines].
    Tajana A, Nardi D, Veronese M.
    Boll Chim Farm; 1975 Aug 31; 114(8):440-4. PubMed ID: 810149
    [No Abstract] [Full Text] [Related]

  • 11. The halogenated 8-hydroxyquinolines.
    Neldner KH.
    Int J Dermatol; 1977 May 31; 16(4):267-73. PubMed ID: 140848
    [No Abstract] [Full Text] [Related]

  • 12. [Bacteriological and clinical evaluation of cephalosporin preparations in 10 years of experience].
    Catalano G, Abbate GF, Gattoni A, Coraggio F, Altucci P.
    G Ital Chemioter; 1977 May 31; 24(1-2):39-48. PubMed ID: 615761
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Antibacterial therapy of urinary tract infections. Results of a clinical trial with the combination sulfamoxol/Trimethoprim (= CN 3123) (author's transl)].
    Peters HJ, Nuri M, Popa G.
    MMW Munch Med Wochenschr; 1977 Mar 25; 119(12):409-12. PubMed ID: 404528
    [Abstract] [Full Text] [Related]

  • 15. [Indices for the user of halogenized 8-hydroxyquinolines in dermatology].
    Levkov AA, Dubiaga AN.
    Vestn Dermatol Venerol; 1977 Feb 25; (2):69-72. PubMed ID: 404774
    [No Abstract] [Full Text] [Related]

  • 16. [Antibiotic sensitivity and immediate clinical response in urinary tract infections].
    Bugnon A, Sakellaridès E, Schelling JL, Bonifas V.
    Schweiz Med Wochenschr; 1972 Oct 07; 102(40):1407-11. PubMed ID: 4567937
    [No Abstract] [Full Text] [Related]

  • 17. [Cephalotin therapy of urinary infections (author's transl)].
    Klimes M, Drahovský V, Demková A, Valanský L.
    Cas Lek Cesk; 1976 May 28; 115(20-21):630-3. PubMed ID: 776401
    [No Abstract] [Full Text] [Related]

  • 18. [Urinary tract infections due to multiresistant gram negative bacteria].
    Acar JF, Guibert J, Bourquelot P, Brisset JM.
    Nouv Presse Med; 1974 Apr 27; 3(0):69-72. PubMed ID: 4209339
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy.
    Hazra SK, Ghosh S, Kundu SK, Chaudhuri S.
    Lepr India; 1979 Oct 27; 51(4):505-10. PubMed ID: 118304
    [No Abstract] [Full Text] [Related]

  • 20. [Effects and side-effects of ampicillin versus ciclacillin in a double blind randomized trial (author's transl)].
    Rüefli P.
    Schweiz Rundsch Med Prax; 1976 Sep 14; 65(37):1130-4. PubMed ID: 794863
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.